IMPROVING THE TREATMENT TACTICS FOR ACUTE BRONCHITIS ASSOCIATED WITH CARDITIS

Abstract

Acute bronchitis is the most common disease among the population, occupying a significant place in the structure of morbidity. The true incidence of carditis is unknown due to the lack of uniform diagnostic criteria for the disease, even taking into account pathomorphological data and the extreme diversity of clinical symptoms, as well as the lack of clearly established studies. Objective: to evaluate the efficacy of nebulizer therapy with nebutamol and oral levocarnitine in acute bronchitis associated with carditis. Materials and methods. Fifty-five patients with acute bronchitis were examined. The patients were divided into 2 groups: Group I (27 patients) with acute bronchitis associated with carditis; Group II (28 patients) with acute bronchitis. Patients with acute bronchitis associated with carditis were divided into two subgroups: subgroup Ia, including 14 patients who received standard therapy, and subgroup Ib, including 14 patients who received inhaled salbutamol and levocarnitine in addition to standard therapy. Thus, the established efficacy of inhaled salbutamol and oral levocarnitine in acute bronchitis associated with carditis will improve treatment strategies and reduce the duration and incidence of complications.